Clinical and Experimental Immunology

Aims & Scope

Clinical & Experimental Immunology has published research at the cutting edge of translational and clinical immunology since 1966.

We are interested in studies that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice.

The journal is among the foremost journals in the field of translational and clinical immunology, attracting high-quality papers from across the world.

Translation is viewed as a process of applying ideas, insights and discoveries generated through scientific studies to the treatment, prevention or diagnosis of human disease.

Clinical immunology has evolved as a field to encompass the application of state-of-the-art technologies such as next-generation sequencing, metagenomics and high-dimensional phenotyping to understand the mechanisms that govern the outcomes of clinical trials.

Journal articles are received by our dedicated Section Editors and cover basic and clinical investigations into the immunological basis of a wide range of human pathologies including autoimmunity, inflammatory diseases, primary and secondary immunodeficiencies, complement disorders, allergies, infectious diseases, cancer and transplantation rejection.

Research that offers mechanistic insight is particularly encouraged.

Studies that inform clinical practice and those that represent position papers on the classification, diagnosis or treatment of immunological disease are also welcomed.

Any paper which does not fit into one of the sections described below will be assessed by our Editor-in-Chief.

All papers with high relevance to translational immunology are welcome.

Clinical & Experimental Immunology is part of the British Society for Immunology family of journals, including our sibling journal Immunotherapy Advances.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.8
2024	3.40

Journal Rank

Year	Value
2024	3052

Journal Citation Indicator

Year	Value
2024	1616

SJR (SCImago Journal Rank)

Year	Value
2024	1.308

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	162

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

  Citation: 1024

  Authors: C K, C W K, A K L, W K, N L S, I H S, L C W, D S C, M H M, S S C, J J Y

• Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

  Citation: 913

  Authors: L A, M J H J, H, E, A S, S G M, E P

• The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update

  Citation: 892

  Authors: H, C, H, J-F

• Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation

  Citation: 829

  Authors: L, O H, P S, S E

• T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

  Citation: 779

  Authors: J M, S J, C M, N, K H G

• Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

  Citation: 700

  Authors: R, I, E, W, K, K-H MEYER ZUM

• Macrophage activation switching: an asset for the resolution of inflammation

  Citation: 688

  Authors: F, S, A-C, C, B, N, D, G

• Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease

  Citation: 669

  Authors: H-C, M, T, I, S, R P, A

• Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells

  Citation: 590

  Authors: K, J M, L, M J, F P, B P

• The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

  Citation: 581

  Authors: B, G, R I, G M

---